Cardio-Oncology Spotlight: From Veins to Brains: Ischemic Stroke in Patients with Cancer
Dr. Deborah Siegal (The Ottawa Hospital, Ottawa, CA) discusses shifting paradigms in cancer related thrombosis.
All Things Cardio-Oncology
Here is a resource for expanding your understanding of the growing field of cardio-oncology in all its dimensions
Subscribe:.rss.atom.json.md.m3u.pls
Live Last read · last published · next check
Latest episodes
Saves to your Listen queue, to pick up on another day or another device.
Bridging Cancer Care and Heart Health: A New Clinical Practice Statement for Cardio-Oncology
The Multinational Association of Supportive Care in Cancer (MASCC) and IC-OS jointly published a paper titled: “Prevention and management of cardiovascular disease in adults with cancer: an International Cardio-Oncology Society (IC-OS) and Multinational Association of Supportive Care in Cancer (MASCC) clinical practice statement”. This is a critical contribution to the literature because it was…
Cardio-Oncology Spotlight: Joshua Levenson, A Novel Risk Score for ICI Myocarditis
Joshua Levenson MD is an Assistant Professor of Medicine at the University of Pittsburgh School of Medicine. He studied Chemistry at Amherst College followed by medicine at the University of Pittsburgh and internal medicine residency at The University of Michigan. He returned to the University of Pittsburgh Medical Center for Cardiology Fellowship prior to joining faculty in 2017. Dr Levenson is a…
Cardio-Oncology Spotlight: Isabella Mahe, A Post-Hoc Analysis of a Randomised, Non-Inferiority Trial (API-CAT)
Dr. Isabella Mahe is the first author of the API-CAT trial and in this episode she reviews predictors associated with clinically relevant bleeding. Join us for for an in-depth discussion on predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism: a post-hoc analysis of a randomised, non-inferiority trial (API-CAT).
Cardio-Oncology Developments in India
Dr. Suvro Banerjee is a distinguished Cardiologist based in Kolkata, West Bengal, with an impressive experience of 26 years in the field of cardiology. Holding multiple prestigious qualifications including MBBS, MD, MRCP, FRCP, FICC, FCSI, FESC, FACC, and FSCAI. As a testament to his leadership and dedication to the field, he has held several notable positions, including Secretary of the…
Cardio-Oncology Spotlight: BTK Inhibitor-Associated Hypertension
Join Dr Emily Tomasulo (Pennsylvania Hospital, US) and Dr Robert S. Copeland Halperin (Northwell Health System, US) for an in-depth discussion on BTK Inhibitor-Associated Hypertension.
Cardio-Oncology Spotlight: BTK Inhibitors and CV Risks
With the rapid increase in the use of BTK inhibitors managing CV risk is increasingly challenging and important. In this episode leading experts from the University of Pennsylvania medical school guide us through some of these complexities. Watch to the full webinar here: https://www.radcliffecardiology.com/webinars/managing-cv-risk-patients-cll Dr. Emily Tomasulo is a Hematologist/Oncologist who…
Heart to Heart: What if Heart Disease Precedes a Cancer Diagnosis?
On this episode of Heart to Heart patient advocate Lee Ramsey helps us appreciate the value of having a cardiologist engaged in both the assessment and management of CV complications before, during, and after cancer treatment.
Using Imaging in the Early Detection of Amyloidosis
Dr. Abuzaid received his degree in medicine from Ain Shams University, Faculty of Medicine, Cairo, Egypt, 2006. He completed his residency in Internal Medicine at Creighton University, Omaha, Nebraska in 2015 followed by a Fellowship in Cardiovascular Disease, Sidney Kimmel Medical College at Thomas Jefferson University, Christiana Care Health System, Newark, Delaware, 2018 and a Fellowship in…
Heart to Heart: When the Doctor Becomes the Patient
Dr. Alexia Oliver opened our 2025 Global Summit sharing her harrowing account of being on the brink of completing her medical training only to discover she had an aggressive lymphoma. Her treatment was followed by chemotherapy-induced heart failure so severe she was placed on the transplant list, yet she slowly recovered against all expectations. After additional setbacks—including bilateral hip…